You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

first-line drugs

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Drug Resistant Epilepsy Trial in Jakarta Pusat, Jakarta (Valproic acid, Carbamazepin, Phenytoin)

Recruiting
  • Drug Resistant Epilepsy
  • Valproic acid
  • +5 more
  • Jakarta Pusat, Jakarta, Indonesia
  • +2 more
Jan 14, 2023

Primary Immune Thrombocytopenia Trial (2.5mg/d Hetrombopag)

Not yet recruiting
  • Primary Immune Thrombocytopenia
  • 2.5mg/d Hetrombopag
  • (no location specified)
Mar 28, 2022

d to Treat Drug Sensitive Tuberculosis in Breastfeeding

Recruiting
  • Tuberculosis Active
  • +2 more
  • First line tuberculosis treatment
  • Kampala, Uganda
    Infectious Diseases Institute
Apr 22, 2023

Atrial Fibrillation Trial in Bronx, Cleveland, Philadelphia (Anti Arrhythmics, Pulmonary Vein Isolation performed by Radio

Recruiting
  • Atrial Fibrillation
  • Anti Arrhythmics
  • Pulmonary Vein Isolation performed by Radio Frequency Catheter Ablation
  • Tucson, Arizona
  • +4 more
Sep 28, 2022

Axitinib Dose Reduction and Interruption for Adverse Event

Completed
  • Renal Cell Carcinoma
  • New York, New York
    Pfizer
Sep 15, 2022

Learn More About How WellTreatment Works When Given After

Not yet recruiting
  • Unresectable Hepatocellular Carcinoma
  • Baltimore, Maryland
  • +19 more
Oct 31, 2023

Plasmodium Falciparum Malaria (Uncomplicated) Trial in Bangladesh, Cambodia, Indonesia (Artemether-lumefantrine+amodiaquine,

Recruiting
  • Plasmodium Falciparum Malaria (Uncomplicated)
  • Cox's Bāzār, Chittagong, Bangladesh
  • +3 more
Jan 31, 2022

Locally Advanced Unresectable Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8

Recruiting
  • Locally Advanced Pancreatic Carcinoma
  • +3 more
  • Biopsy
  • +5 more
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center EDDOP
Nov 30, 2022

Inetetamab Combined With Pyrotinib and Vinorelbine as First-line

Recruiting
  • Breast Neoplasms
  • Nanjing, Jiangsu, China
    Jiangsu Provincial People's Hospital
Mar 16, 2023

Advanced Mucosal Melanoma Trial (Envafolimab combined with recombinant human endostatin and first-line chemo)

Not yet recruiting
  • Advanced Mucosal Melanoma
  • Envafolimab combined with recombinant human endostatin and first-line chemotherapy
  • (no location specified)
Sep 15, 2023

HR Positive HER2 Negative Advanced Breast Cancer Trial in Tianjin (Chidamide)

Recruiting
  • HR Positive HER2 Negative Advanced Breast Cancer
  • Tianjin, China
    天津市肿瘤医院
May 26, 2023

Anti-tuberculosis Drugs in Gastrectomized Patients

Completed
  • Tuberculosis
  • +2 more
  • standard first line anti-TB drugs
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    Respiratory Clinic, National Cancer Center
Sep 24, 2020

Helicobacter Pylori Infection Trial in New Taipei City (Vonoprazan and Amoxicillin, Lansoprazole, Amoxicillin, Clarithromycin

Recruiting
  • Helicobacter Pylori Infection
  • Vonoprazan and Amoxicillin
  • Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole
  • New Taipei City, Taiwan
    Fu Jen Catholic University Hospital, Fu Jen Catholic University
Dec 3, 2023

Advanced Biliary Tract Cancer Trial (anlotinib+TQB2450+nab-paclitaxel+cisplatin)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • (no location specified)
Apr 2, 2023

Can Digitally Delivered First-line Osteoarthritis Treatment

Recruiting
  • Health Services Accessibility
  • +2 more
  • Digitally delivered first-line treatment for osteoarthritis
  • Face-to-face first-line treatment for osteoarthritis
  • Malmö, Sweden
    Joint Academy
Nov 20, 2023

Hepatocellular Carcinoma Trial in Beijing (Lenvatinib Plus Tislelizumab, Transarterial Chemoembolization(TACE))

Recruiting
  • Hepatocellular Carcinoma
  • Lenvatinib Plus Tislelizumab
  • Transarterial Chemoembolization(TACE)
  • Beijing, Beijing, China
    Nan Zhang
Apr 22, 2023

Tislelizumab Combined With Chemotherapy in First-line Treatment

Active, not recruiting
  • Tislelizumab
  • +3 more
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 6, 2023

Follicular Lymphoma, Low Grade Non-Hodgkin's Lymphoma, Adult Trial in Boston (Epcoritamab, Rituximab)

Not yet recruiting
  • Follicular Lymphoma
  • Low Grade Non-Hodgkin's Lymphoma, Adult
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 13, 2023

Hiv Trial (Doravirine 100Mg Tab, Raltegravir 600Mg Tab, Biktarvy 50/200/25 Tab)

Not yet recruiting
  • Hiv
  • Doravirine 100Mg Tab
  • +2 more
  • (no location specified)
Dec 15, 2022

Gastric Cancer Trial (Tislelizumab, 5Fu, Paclitaxel injection)

Not yet recruiting
  • Gastric Cancer
  • (no location specified)
Feb 21, 2023

Hodgkin Lymphoma Trial in Cologne (Pembrolizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Cologne, Germany
    1st Department of Medicine, Cologne University Hospital
Sep 19, 2023

First-Line Serplulimab Plus Chemotherapy in Treatment of

Not yet recruiting
  • Lung Cancer
  • Serplulimab plus chemotherapy
  • (no location specified)
May 16, 2023

NSCLC Trial in Wuhan (Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel)

Recruiting
  • Non-small Cell Lung Cancer
  • Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel
  • Wuhan, Hubei, China
    Union hospital
Feb 20, 2023

Nasopharyngeal Carcinoma Trial in Zhongshan (Anrotinib plus Tirelizumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Anrotinib plus Tirelizumab
  • Zhongshan, Guangdong, China
    Zhongshan City People's Hospital
Jul 31, 2023

Colorectal Carcinoma Trial (Fruquintinib?Capecitabine Tablets)

Not yet recruiting
  • Colorectal Carcinoma
  • Fruquintinib、Capecitabine Tablets
  • (no location specified)
Oct 30, 2023